Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia

door DeRemer, David L, Katsanevas, Katerina, Ustun, Celalettin
Gepubliceerd in 2011

Anti-angiogenic therapy for cancer: An update

door Al-Husein, Belal, Abdalla, Maha, Trepte, Morgan, DeRemer, David L., Somanath, Payaningal R.
Gepubliceerd in 2012

Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo

door Goc, Anna, Al-Husein, Belal, Katsanevas, Katerina, Steinbach, Alison, Lou, Uvette, Sabbineni, Harika, DeRemer, David L., Somanath, Payaningal R.
Gepubliceerd in 2014

Pharmacy Student Performance in a Capstone Course Utilizing the Pharmacists’ Patient Care Process

door Phillips, Beth Bryles, Newsome, Andrea Sikora, Bland, Christopher M., Palmer, Russ, Smith, Katie, DeRemer, David L., Phan, Stephanie V.
Gepubliceerd in Am J Pharm Educ (2019)

Newly diagnosed cardiovascular disease in patients treated with immune checkpoint inhibitors: a retrospective analysis of patients at an academic tertiary care center

door Waheed, Nida, Fradley, Michael G., DeRemer, David L., Mahmoud, Ahmad, Shah, Chintan P., Langaee, Taimour Y., Lipori, Gloria P., March, Keith, Pepine, Carl J., Cooper-DeHoff, Rhonda M., Wu, Yonghui, Gong, Yan
Gepubliceerd in Cardiooncology (2021)